BACKGROUND: In terms of clinical outcomes, women with schizophrenia seem to fare better then men, but appear more vulnerable to psychotic illness in the period after birth and menopause. As these vulnerable periods to psychosis are associated with estrogen withdrawal, this hormone has been proposed as a treatment for schizophrenia. OBJECTIVES: To evaluate the clinical effects of estrogens alone or in combination with progesterone,
CITATION STYLE
Chua, W. L. L., Izquierdo de Santiago, A., Kulkarni, J., & Mortimer, A. (2005). Estrogen for schizophrenia. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd004719.pub2
Mendeley helps you to discover research relevant for your work.